Francine Behar-Cohen
Fondateur chez Eyevensys SAS
Profil
Francine Behar-Cohen is the founder.
She founded Kiora Pharmaceuticals, Inc. in 1998, EarlySight SA in 2019, and Eyevensys SAS in 2008.
At Eyevensys SAS, she holds the title of Director & Chief Innovation Officer.
Postes actifs de Francine Behar-Cohen
Sociétés | Poste | Début |
---|---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Fondateur | 08/12/2008 |
Anciens postes connus de Francine Behar-Cohen
Sociétés | Poste | Fin |
---|---|---|
EarlySight SA
EarlySight SA Medical SpecialtiesHealth Technology EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland. | Fondateur | - |
KIORA PHARMACEUTICALS, INC. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
EarlySight SA
EarlySight SA Medical SpecialtiesHealth Technology EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland. | Health Technology |